HER2 and response to paclitaxel in node-positive breast cancer by Hayes Daniel F, Thor Ann D, Dressler Lynn G, Weaver Donald, Edgerton Susan, Cowan David, Broadwater Gloria, Goldstein Lori J, Martino Silvana, Ingle James N, Henderson I Craig, Norton Larry, Winer Eric P, Hudis Clifford A, Ellis Matthew J, Berry Donald A, Cancer and Leukemia Group B (CALGB) Investigators in The New England journal of medicine (2007).

[PMID: 17928597] PubMed


Discussed In Paper


Dosing Information

No dosing information annotated.